Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-18

Clinical Trial Update: The Effect of Soluble Epoxide Hydrolase (SEH) on Depression

View source ↗

Summary

A completed clinical trial evaluated the effect of a soluble epoxide hydrolase inhibitor on Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soluble Epoxide Hydrolase inhibitor (SEHi)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Major Depressive Disorder | Status: COMPLETED